Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Retained Earnings (2023 - 2025)

Camp4 Therapeutics' Retained Earnings history spans 3 years, with the latest figure at -$292.2 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 37.99% year-over-year to -$292.2 million; the TTM value through Dec 2025 reached -$292.2 million, down 37.99%, while the annual FY2025 figure was -$292.2 million, 37.99% down from the prior year.
  • Retained Earnings for Q4 2025 was -$292.2 million at Camp4 Therapeutics, down from -$251.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$160.0 million in Q4 2023 and bottomed at -$292.2 million in Q4 2025.
  • The 3-year median for Retained Earnings is -$224.2 million (2025), against an average of -$225.0 million.
  • The largest YoY upside for Retained Earnings was 26.92% in 2025 against a maximum downside of 37.99% in 2025.
  • A 3-year view of Retained Earnings shows it stood at -$160.0 million in 2023, then tumbled by 32.38% to -$211.8 million in 2024, then tumbled by 37.99% to -$292.2 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Retained Earnings are -$292.2 million (Q4 2025), -$251.9 million (Q3 2025), and -$236.8 million (Q2 2025).